The timeline of metalloprotease events during oligofructose induced equine laminitis development.

This research explores the involvement of matrix metalloproteases (MMPs) in the development of laminitis in horses following an administration of oligofructose. The study finds that certain MMPs, previously thought to cause laminitis, do not appear to initiate the disease. Instead, other proteases and the degradation of other lamellar matrix components may be involved.

Objective and Method

This research study aimed to better understand the role and timeline of matrix metalloproteases (MMPs) during the development of laminitis, a painful condition affecting the horse’s hoof. The researchers administered a bolus of oligofructose (OF) via nasogastric intubation to five clinically normal Standardbred horses, and observed development of laminitis for 48 hours. They conducted lamellar biopsies at various intervals during the treatment period for subsequent analysis.

• Matrix metalloproteases (MMPs): Enzymes that have the ability to break down extracellular matrix proteins.
• Laminitis: A painful and potentially crippling disease affecting horses, causing inflammation of the laminae tissue that bonds the hoof wall to the pedal (coffin) bone.
• Oligofructose (OF): A type of carbohydrate derived from plant fibers. It’s used here to induce laminitis for experimental purposes.

Results

The researchers concluded through their investigations that the activation of proMMP-2 appears to occur in line with or following damages to the lamellar basement membrane (BM), however, they found no evidence of proMMP-9 activation during the laminitis induction by OF. Also, they noted an increase in the gene expression of aggrecanase shortly after OF administration, a similar timeline to BM changes. On the other hand, the expression of TIMP-2, a regulator of MMPs, was found to decrease during laminitis development.

• proMMP-2 and proMMP-9: Inactive forms (proenzymes) of two different types of MMPs.
• Lamellar Basement Membrane (BM): A layer present in the horse’s hoof, hypothesized to be involved in laminitis development.
• Aggrecanase: An enzyme involved in breaking down specific components of the extracellular matrix, particularly aggrecan.
• TIMP-2: Tissue inhibitor of MMPs, regulates the enzymatic activities of MMPs.

Conclusions

Contrary to traditional thoughts, the study concludes that certain MMPs, specifically the MMP-2/MT1-MMP complex, do not play a significant role in causing the initial damage to the lamellar basement membrane during laminitis development in the horses subjected to OF. Furthermore, it suggests that the gene expression of aggrecanase and TIMP-2 may be tied to changes within the lamellar basement membrane during the disease’s progression. Therefore, proteins other than MMPs, along with the degradation of other parts of the lamellar matrix, should be considered when studying the onset of laminitis. This research reshapes the understanding of laminitis’ etiology and could impact future diagnostic and therapeutic developments for the disease.